Coronado Biosciences, Inc. (NASDAQ:CNDO)

CAPS Rating: 2 out of 5

Results 1 - 7 of 7

Recs

0
Member Avatar Flygal5 (99.26) Submitted: 9/11/2014 2:15:39 PM : Underperform Start Price: $1.81 CNDO Score: -1.77

repeating here

Recs

0
Member Avatar OklaBoston (67.44) Submitted: 8/22/2014 4:37:45 PM : Outperform Start Price: $1.91 CNDO Score: -3.94

Senior officers have been buying lots on the open market regularly for years now.

To me that's a much better indication of a stock's potential than membership in the S&P 500.

Recs

0
Member Avatar JavaChipFool (60.04) Submitted: 2/5/2014 3:22:21 PM : Outperform Start Price: $2.45 CNDO Score: -38.98

Biotech gamble, down but not out

Recs

0
Member Avatar fatmoneyrz (97.91) Submitted: 10/14/2013 2:19:27 PM : Outperform Start Price: $2.10 CNDO Score: -29.47

Nice entry on nice little biotech with a solid pipeline and solid cash position.

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/6/2013 7:30:28 PM : Underperform Start Price: $10.02 CNDO Score: +100.19

Biotech. Big losses. Selling tons of stock.

Recs

0
Member Avatar dwhit110 (< 20) Submitted: 7/15/2013 12:22:21 PM : Outperform Start Price: $8.63 CNDO Score: -97.93

The company has a smart and experienced executive team with past pharma experiencing getting drugs from the trial to FDA approved stage.

It's all a question of if their innovative solutions work as they're supposed to.

Recs

1
Member Avatar jcarnoldsf (22.57) Submitted: 1/25/2012 6:12:22 PM : Outperform Start Price: $6.18 CNDO Score: -126.69

This young biotech has a top-notch management team and an exciting roster of drugs entering final stage testing. The drugs are targeting autoimmune diseases and cancer. The most novel is an approach using parasites to activate the immune system. Has potential to be a big winner - buy now while it's still cheap!

Results 1 - 7 of 7

Featured Broker Partners


Advertisement